GrippeCanadaV3, Main, Exploration, bibRecord, 000052

Examination of the British Columbia influenza prevention policy for healthcare workers: Phase 1 qualitative case study.

Identifieur interne : 000052 ( Main/Exploration ); précédent : 000051; suivant : 000053

Examination of the British Columbia influenza prevention policy for healthcare workers: Phase 1 qualitative case study.

Auteurs : Charmaine M. Mcpherson [Canada] ; Donna M. Halperin [Canada] ; Bonnie Henry [Canada] ; Antonia M. Di Castri [Canada] ; Jeffrey C. Kwong [Canada]

Source :

Human vaccines & immunotherapeutics [ 2164-554X ] ; 2018.

RBID : pubmed:29617181

Descripteurs français

KwdFr :
- Colombie-Britannique, Différences de pratiques professionnelles, Grippe humaine (), Groupes focalisés, Humains, Masques, Mise en oeuvre des programmes de santé, Personnel de santé (législation et jurisprudence), Politique (principe), Recherche qualitative, Vaccination (législation et jurisprudence), Vaccins antigrippaux (administration et posologie).
MESH :
- administration et posologie : Vaccins antigrippaux.
- législation et jurisprudence : Personnel de santé, Vaccination.
- Colombie-Britannique, Différences de pratiques professionnelles, Grippe humaine, Groupes focalisés, Humains, Masques, Mise en oeuvre des programmes de santé, Politique (principe), Recherche qualitative.

English descriptors

KwdEn :
- British Columbia, Focus Groups, Health Personnel (legislation & jurisprudence), Health Plan Implementation, Humans, Influenza Vaccines (administration & dosage), Influenza, Human (prevention & control), Masks, Policy, Professional Practice Gaps, Qualitative Research, Vaccination (legislation & jurisprudence).
MESH :
- chemical , administration & dosage : Influenza Vaccines.
- geographic : British Columbia.
- legislation & jurisprudence : Health Personnel, Vaccination.
- prevention & control : Influenza, Human.
- Focus Groups, Health Plan Implementation, Humans, Masks, Policy, Professional Practice Gaps, Qualitative Research.

Abstract

In August 2012, British Columbia became the first Canadian province to implement a province-wide Influenza Prevention Policy requiring all healthcare workers (HCWs) in residential and acute care facilities to either be immunized against influenza, or wear masks in patient care areas during the influenza season. This qualitative case study sought to understand the key facilitators and barriers involved in developing and implementing British Columbia's Influenza Prevention Policy. An explanatory qualitative case study approach was selected for this project. Data were collected through the review of 110 documents (policy and planning documents, implementation tools, press releases, communication materials, etc.), and through 7 focus groups with policy implementation team members (n = 48). Focus group interview transcripts were analyzed using Framework Analysis methods, and Prior's approach guided document analysis. Four themes were identified: (1) Clashing paradigms, (2) Policy implementation gaps, (3) Pathways of power, and (4) Personal impacts. Issues embedded in macro-, meso-, and micro-level contexts, and planning across the province, were identified as critical to policy implementation. A province-wide approach with senior-level engagement and dedicated resources is critical in a province-wide influenza prevention policy for HCW. Recommendations to improve large-scale implementation of condition-of-service influenza policies include: engaging stakeholders early, considering the complexity of political contexts, allotting time to plan appropriately, developing 'enforcement' plans, and providing education and skills to frontline providers.

DOI: 10.1080/21645515.2018.1460296
PubMed: 29617181

Affiliations:

Canada

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000050
to stream Main, to step Curation: 000050

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Examination of the British Columbia influenza prevention policy for healthcare workers: Phase 1 qualitative case study.</title>
<author><name sortKey="Mcpherson, Charmaine M" sort="Mcpherson, Charmaine M" uniqKey="Mcpherson C" first="Charmaine M" last="Mcpherson">Charmaine M. Mcpherson</name>
<affiliation wicri:level="1"><nlm:affiliation>a Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority , Halifax , NS , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>a Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority , Halifax , NS </wicri:regionArea>
<wicri:noRegion>NS </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>b School of Nursing, St. Francis Xavier University , Antigonish , NS , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>b School of Nursing, St. Francis Xavier University , Antigonish , NS </wicri:regionArea>
<wicri:noRegion>NS </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>c Risk Mitigation - Primary and Acute Care Branch, System Strategy and Performance Division , Department of Health and Wellness , Province of Nova Scotia, Halifax , NS , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>c Risk Mitigation - Primary and Acute Care Branch, System Strategy and Performance Division , Department of Health and Wellness , Province of Nova Scotia, Halifax , NS </wicri:regionArea>
<wicri:noRegion>NS </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Halperin, Donna M" sort="Halperin, Donna M" uniqKey="Halperin D" first="Donna M" last="Halperin">Donna M. Halperin</name>
<affiliation wicri:level="1"><nlm:affiliation>a Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority , Halifax , NS , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>a Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority , Halifax , NS </wicri:regionArea>
<wicri:noRegion>NS </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>b School of Nursing, St. Francis Xavier University , Antigonish , NS , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>b School of Nursing, St. Francis Xavier University , Antigonish , NS </wicri:regionArea>
<wicri:noRegion>NS </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Henry, Bonnie" sort="Henry, Bonnie" uniqKey="Henry B" first="Bonnie" last="Henry">Bonnie Henry</name>
<affiliation wicri:level="1"><nlm:affiliation>d School of Population and Public Health, Faculty of Medicine, University of British Columbia, and Office of the Provincial Health Officer, Ministry of Health , BC , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>d School of Population and Public Health, Faculty of Medicine, University of British Columbia, and Office of the Provincial Health Officer, Ministry of Health , BC </wicri:regionArea>
<wicri:noRegion>BC </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Di Castri, Antonia M" sort="Di Castri, Antonia M" uniqKey="Di Castri A" first="Antonia M" last="Di Castri">Antonia M. Di Castri</name>
<affiliation wicri:level="1"><nlm:affiliation>a Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority , Halifax , NS , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>a Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority , Halifax , NS </wicri:regionArea>
<wicri:noRegion>NS </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kwong, Jeffrey C" sort="Kwong, Jeffrey C" uniqKey="Kwong J" first="Jeffrey C" last="Kwong">Jeffrey C. Kwong</name>
<affiliation wicri:level="1"><nlm:affiliation>e Institute for Clinical Evaluative Sciences , Toronto , ON , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>e Institute for Clinical Evaluative Sciences , Toronto , ON </wicri:regionArea>
<wicri:noRegion>ON </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>f Public Health Ontario , Toronto , ON , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>f Public Health Ontario , Toronto , ON </wicri:regionArea>
<wicri:noRegion>ON </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>g Department of Family & Community Medicine , University of Toronto , Toronto , ON , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>g Department of Family & Community Medicine , University of Toronto , Toronto , ON </wicri:regionArea>
<wicri:noRegion>ON </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>h Dalla Lana School of Public Health, University of Toronto , Toronto , ON , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>h Dalla Lana School of Public Health, University of Toronto , Toronto , ON </wicri:regionArea>
<wicri:noRegion>ON </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>i University Health Network , Toronto , ON , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>i University Health Network , Toronto , ON </wicri:regionArea>
<wicri:noRegion>ON </wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29617181</idno>
<idno type="pmid">29617181</idno>
<idno type="doi">10.1080/21645515.2018.1460296</idno>
<idno type="wicri:Area/Main/Corpus">000050</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000050</idno>
<idno type="wicri:Area/Main/Curation">000050</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000050</idno>
<idno type="wicri:Area/Main/Exploration">000050</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Examination of the British Columbia influenza prevention policy for healthcare workers: Phase 1 qualitative case study.</title>
<author><name sortKey="Mcpherson, Charmaine M" sort="Mcpherson, Charmaine M" uniqKey="Mcpherson C" first="Charmaine M" last="Mcpherson">Charmaine M. Mcpherson</name>
<affiliation wicri:level="1"><nlm:affiliation>a Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority , Halifax , NS , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>a Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority , Halifax , NS </wicri:regionArea>
<wicri:noRegion>NS </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>b School of Nursing, St. Francis Xavier University , Antigonish , NS , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>b School of Nursing, St. Francis Xavier University , Antigonish , NS </wicri:regionArea>
<wicri:noRegion>NS </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>c Risk Mitigation - Primary and Acute Care Branch, System Strategy and Performance Division , Department of Health and Wellness , Province of Nova Scotia, Halifax , NS , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>c Risk Mitigation - Primary and Acute Care Branch, System Strategy and Performance Division , Department of Health and Wellness , Province of Nova Scotia, Halifax , NS </wicri:regionArea>
<wicri:noRegion>NS </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Halperin, Donna M" sort="Halperin, Donna M" uniqKey="Halperin D" first="Donna M" last="Halperin">Donna M. Halperin</name>
<affiliation wicri:level="1"><nlm:affiliation>a Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority , Halifax , NS , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>a Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority , Halifax , NS </wicri:regionArea>
<wicri:noRegion>NS </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>b School of Nursing, St. Francis Xavier University , Antigonish , NS , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>b School of Nursing, St. Francis Xavier University , Antigonish , NS </wicri:regionArea>
<wicri:noRegion>NS </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Henry, Bonnie" sort="Henry, Bonnie" uniqKey="Henry B" first="Bonnie" last="Henry">Bonnie Henry</name>
<affiliation wicri:level="1"><nlm:affiliation>d School of Population and Public Health, Faculty of Medicine, University of British Columbia, and Office of the Provincial Health Officer, Ministry of Health , BC , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>d School of Population and Public Health, Faculty of Medicine, University of British Columbia, and Office of the Provincial Health Officer, Ministry of Health , BC </wicri:regionArea>
<wicri:noRegion>BC </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Di Castri, Antonia M" sort="Di Castri, Antonia M" uniqKey="Di Castri A" first="Antonia M" last="Di Castri">Antonia M. Di Castri</name>
<affiliation wicri:level="1"><nlm:affiliation>a Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority , Halifax , NS , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>a Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority , Halifax , NS </wicri:regionArea>
<wicri:noRegion>NS </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kwong, Jeffrey C" sort="Kwong, Jeffrey C" uniqKey="Kwong J" first="Jeffrey C" last="Kwong">Jeffrey C. Kwong</name>
<affiliation wicri:level="1"><nlm:affiliation>e Institute for Clinical Evaluative Sciences , Toronto , ON , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>e Institute for Clinical Evaluative Sciences , Toronto , ON </wicri:regionArea>
<wicri:noRegion>ON </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>f Public Health Ontario , Toronto , ON , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>f Public Health Ontario , Toronto , ON </wicri:regionArea>
<wicri:noRegion>ON </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>g Department of Family & Community Medicine , University of Toronto , Toronto , ON , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>g Department of Family & Community Medicine , University of Toronto , Toronto , ON </wicri:regionArea>
<wicri:noRegion>ON </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>h Dalla Lana School of Public Health, University of Toronto , Toronto , ON , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>h Dalla Lana School of Public Health, University of Toronto , Toronto , ON </wicri:regionArea>
<wicri:noRegion>ON </wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>i University Health Network , Toronto , ON , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>i University Health Network , Toronto , ON </wicri:regionArea>
<wicri:noRegion>ON </wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Human vaccines & immunotherapeutics</title>
<idno type="eISSN">2164-554X</idno>
<imprint><date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>British Columbia</term>
<term>Focus Groups</term>
<term>Health Personnel (legislation & jurisprudence)</term>
<term>Health Plan Implementation</term>
<term>Humans</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Masks</term>
<term>Policy</term>
<term>Professional Practice Gaps</term>
<term>Qualitative Research</term>
<term>Vaccination (legislation & jurisprudence)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Colombie-Britannique</term>
<term>Différences de pratiques professionnelles</term>
<term>Grippe humaine ()</term>
<term>Groupes focalisés</term>
<term>Humains</term>
<term>Masques</term>
<term>Mise en oeuvre des programmes de santé</term>
<term>Personnel de santé (législation et jurisprudence)</term>
<term>Politique (principe)</term>
<term>Recherche qualitative</term>
<term>Vaccination (législation et jurisprudence)</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>British Columbia</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="legislation & jurisprudence" xml:lang="en"><term>Health Personnel</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="législation et jurisprudence" xml:lang="fr"><term>Personnel de santé</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Focus Groups</term>
<term>Health Plan Implementation</term>
<term>Humans</term>
<term>Masks</term>
<term>Policy</term>
<term>Professional Practice Gaps</term>
<term>Qualitative Research</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Colombie-Britannique</term>
<term>Différences de pratiques professionnelles</term>
<term>Grippe humaine</term>
<term>Groupes focalisés</term>
<term>Humains</term>
<term>Masques</term>
<term>Mise en oeuvre des programmes de santé</term>
<term>Politique (principe)</term>
<term>Recherche qualitative</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In August 2012, British Columbia became the first Canadian province to implement a province-wide Influenza Prevention Policy requiring all healthcare workers (HCWs) in residential and acute care facilities to either be immunized against influenza, or wear masks in patient care areas during the influenza season. This qualitative case study sought to understand the key facilitators and barriers involved in developing and implementing British Columbia's Influenza Prevention Policy. An explanatory qualitative case study approach was selected for this project. Data were collected through the review of 110 documents (policy and planning documents, implementation tools, press releases, communication materials, etc.), and through 7 focus groups with policy implementation team members (n = 48). Focus group interview transcripts were analyzed using Framework Analysis methods, and Prior's approach guided document analysis. Four themes were identified: (1) Clashing paradigms, (2) Policy implementation gaps, (3) Pathways of power, and (4) Personal impacts. Issues embedded in macro-, meso-, and micro-level contexts, and planning across the province, were identified as critical to policy implementation. A province-wide approach with senior-level engagement and dedicated resources is critical in a province-wide influenza prevention policy for HCW. Recommendations to improve large-scale implementation of condition-of-service influenza policies include: engaging stakeholders early, considering the complexity of political contexts, allotting time to plan appropriately, developing 'enforcement' plans, and providing education and skills to frontline providers.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29617181</PMID>
<DateCompleted><Year>2019</Year>
<Month>04</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>04</Month>
<Day>29</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>14</Volume>
<Issue>8</Issue>
<PubDate><Year>2018</Year>
</PubDate>
</JournalIssue>
<Title>Human vaccines & immunotherapeutics</Title>
<ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
</Journal>
<ArticleTitle>Examination of the British Columbia influenza prevention policy for healthcare workers: Phase 1 qualitative case study.</ArticleTitle>
<Pagination><MedlinePgn>1883-1889</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2018.1460296</ELocationID>
<Abstract><AbstractText>In August 2012, British Columbia became the first Canadian province to implement a province-wide Influenza Prevention Policy requiring all healthcare workers (HCWs) in residential and acute care facilities to either be immunized against influenza, or wear masks in patient care areas during the influenza season. This qualitative case study sought to understand the key facilitators and barriers involved in developing and implementing British Columbia's Influenza Prevention Policy. An explanatory qualitative case study approach was selected for this project. Data were collected through the review of 110 documents (policy and planning documents, implementation tools, press releases, communication materials, etc.), and through 7 focus groups with policy implementation team members (n = 48). Focus group interview transcripts were analyzed using Framework Analysis methods, and Prior's approach guided document analysis. Four themes were identified: (1) Clashing paradigms, (2) Policy implementation gaps, (3) Pathways of power, and (4) Personal impacts. Issues embedded in macro-, meso-, and micro-level contexts, and planning across the province, were identified as critical to policy implementation. A province-wide approach with senior-level engagement and dedicated resources is critical in a province-wide influenza prevention policy for HCW. Recommendations to improve large-scale implementation of condition-of-service influenza policies include: engaging stakeholders early, considering the complexity of political contexts, allotting time to plan appropriately, developing 'enforcement' plans, and providing education and skills to frontline providers.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McPherson</LastName>
<ForeName>Charmaine M</ForeName>
<Initials>CM</Initials>
<AffiliationInfo><Affiliation>a Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority , Halifax , NS , Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>b School of Nursing, St. Francis Xavier University , Antigonish , NS , Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>c Risk Mitigation - Primary and Acute Care Branch, System Strategy and Performance Division , Department of Health and Wellness , Province of Nova Scotia, Halifax , NS , Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Halperin</LastName>
<ForeName>Donna M</ForeName>
<Initials>DM</Initials>
<AffiliationInfo><Affiliation>a Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority , Halifax , NS , Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>b School of Nursing, St. Francis Xavier University , Antigonish , NS , Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Henry</LastName>
<ForeName>Bonnie</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>d School of Population and Public Health, Faculty of Medicine, University of British Columbia, and Office of the Provincial Health Officer, Ministry of Health , BC , Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Di Castri</LastName>
<ForeName>Antonia M</ForeName>
<Initials>AM</Initials>
<AffiliationInfo><Affiliation>a Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and the Nova Scotia Health Authority , Halifax , NS , Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kwong</LastName>
<ForeName>Jeffrey C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo><Affiliation>e Institute for Clinical Evaluative Sciences , Toronto , ON , Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>f Public Health Ontario , Toronto , ON , Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>g Department of Family & Community Medicine , University of Toronto , Toronto , ON , Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>h Dalla Lana School of Public Health, University of Toronto , Toronto , ON , Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>i University Health Network , Toronto , ON , Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Program Delivery and Evaluation Group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>PIR 124309</GrantID>
<Agency>CIHR</Agency>
<Country>Canada</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2018</Year>
<Month>05</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Hum Vaccin Immunother</MedlineTA>
<NlmUniqueID>101572652</NlmUniqueID>
<ISSNLinking>2164-5515</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D001955" MajorTopicYN="N" Type="Geographic">British Columbia</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017144" MajorTopicYN="N">Focus Groups</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName>
<QualifierName UI="Q000331" MajorTopicYN="Y">legislation & jurisprudence</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006284" MajorTopicYN="N">Health Plan Implementation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008397" MajorTopicYN="N">Masks</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D057766" MajorTopicYN="Y">Policy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000071836" MajorTopicYN="N">Professional Practice Gaps</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
<QualifierName UI="Q000331" MajorTopicYN="Y">legislation & jurisprudence</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">British Columbia</Keyword>
<Keyword MajorTopicYN="Y">condition-of-service policy</Keyword>
<Keyword MajorTopicYN="Y">health care workers</Keyword>
<Keyword MajorTopicYN="Y">immunization policy</Keyword>
<Keyword MajorTopicYN="Y">influenza</Keyword>
<Keyword MajorTopicYN="Y">influenza immunization</Keyword>
<Keyword MajorTopicYN="Y">policy case study</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year>
<Month>4</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2019</Year>
<Month>4</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2018</Year>
<Month>4</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">29617181</ArticleId>
<ArticleId IdType="doi">10.1080/21645515.2018.1460296</ArticleId>
<ArticleId IdType="pmc">PMC6149879</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Vaccine. 2011 Nov 21;29(50):9398-403</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21945495</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Health Serv Res Policy. 2008 Jan;13 Suppl 1:35-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18325167</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Control Hosp Epidemiol. 2010 Oct;31(10):987-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20807037</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Control Hosp Epidemiol. 2000 Jul;21(7):449-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10926394</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Promot Int. 2009 Dec;24(4):434-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19819897</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Control Hosp Epidemiol. 2011 May;32(5):444-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21515974</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Infect Control. 2012 Oct;40(8):771-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22325484</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Med Res Methodol. 2013 Sep 18;13:117</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24047204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Recomm Rep. 2004 May 28;53(RR-6):1-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15163927</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Control Hosp Epidemiol. 2010 Mar;31(3):233-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20055666</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Control Hosp Epidemiol. 2004 Nov;25(11):918-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15566024</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatrics. 2015 Oct;136(4):809-18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26347432</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2010 Feb 15;50(4):459-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20064039</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 1997 Jan;175(1):1-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8985189</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>CMAJ. 2010 Sep 7;182(12):E542-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20643836</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Control Hosp Epidemiol. 2010 Sep;31(9):881-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20653445</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Infect Control. 2007 Feb;35(1):33-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17276789</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Equity Health. 2016 Aug 19;15(1):129</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27539080</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Control Hosp Epidemiol. 2010 May;31(5):456-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20233060</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Control Hosp Epidemiol. 2011 Jun;32(6):616-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21558776</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Recomm Rep. 2006 Feb 24;55(RR-2):1-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16498385</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Mcpherson, Charmaine M" sort="Mcpherson, Charmaine M" uniqKey="Mcpherson C" first="Charmaine M" last="Mcpherson">Charmaine M. Mcpherson</name>
</noRegion>
<name sortKey="Di Castri, Antonia M" sort="Di Castri, Antonia M" uniqKey="Di Castri A" first="Antonia M" last="Di Castri">Antonia M. Di Castri</name>
<name sortKey="Halperin, Donna M" sort="Halperin, Donna M" uniqKey="Halperin D" first="Donna M" last="Halperin">Donna M. Halperin</name>
<name sortKey="Halperin, Donna M" sort="Halperin, Donna M" uniqKey="Halperin D" first="Donna M" last="Halperin">Donna M. Halperin</name>
<name sortKey="Henry, Bonnie" sort="Henry, Bonnie" uniqKey="Henry B" first="Bonnie" last="Henry">Bonnie Henry</name>
<name sortKey="Kwong, Jeffrey C" sort="Kwong, Jeffrey C" uniqKey="Kwong J" first="Jeffrey C" last="Kwong">Jeffrey C. Kwong</name>
<name sortKey="Kwong, Jeffrey C" sort="Kwong, Jeffrey C" uniqKey="Kwong J" first="Jeffrey C" last="Kwong">Jeffrey C. Kwong</name>
<name sortKey="Kwong, Jeffrey C" sort="Kwong, Jeffrey C" uniqKey="Kwong J" first="Jeffrey C" last="Kwong">Jeffrey C. Kwong</name>
<name sortKey="Kwong, Jeffrey C" sort="Kwong, Jeffrey C" uniqKey="Kwong J" first="Jeffrey C" last="Kwong">Jeffrey C. Kwong</name>
<name sortKey="Kwong, Jeffrey C" sort="Kwong, Jeffrey C" uniqKey="Kwong J" first="Jeffrey C" last="Kwong">Jeffrey C. Kwong</name>
<name sortKey="Mcpherson, Charmaine M" sort="Mcpherson, Charmaine M" uniqKey="Mcpherson C" first="Charmaine M" last="Mcpherson">Charmaine M. Mcpherson</name>
<name sortKey="Mcpherson, Charmaine M" sort="Mcpherson, Charmaine M" uniqKey="Mcpherson C" first="Charmaine M" last="Mcpherson">Charmaine M. Mcpherson</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000052 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000052 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeCanadaV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:29617181
   |texte=   Examination of the British Columbia influenza prevention policy for healthcare workers: Phase 1 qualitative case study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:29617181" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeCanadaV3

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 13:36:58 2020. Site generation: Sat Sep 26 07:06:42 2020

	Corpus GrippeCanadaV3
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Corpus GrippeCanadaV3

Examination of the British Columbia influenza prevention policy for healthcare workers: Phase 1 qualitative case study.

Examination of the British Columbia influenza prevention policy for healthcare workers: Phase 1 qualitative case study.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki